Stocks · Health care · Pharmaceutical Preparations

Annexon, Inc.

ANNX Clue Score37
United States Fiscal year ends December CIK 0001528115 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Douglas Love
24 Sep 2026
President and CEO
Buy
26,065
$3.83
$99.83K
Ted Yednock
11 Jun 2026
EVP & Chief Innovation Officer
Exercised, kept
30,646
$1.85
$56.70K
Muneer A Satter
28 May 2026
Director
Buy indirect
613,497
$5.41
$3.32M
William H. Carson
11 May 2026
Director
Buy
8,000
$5.78
$46.24K
William H. Carson
10 Apr 2026
Director
Buy
8,000
$6.20
$49.60K
William H. Carson
10 Mar 2026
Director
Buy
8,000
$5.67
$45.36K
Jennifer Lew
2 Mar 2026
EVP & Chief Financial Officer
Sell
5,565
$5.42
$30.16K
Dean Richard Artis
2 Mar 2026
EVP & Chief Scientific Officer
Sell
5,894
$5.43
$32.00K
Ted Yednock
2 Mar 2026
EVP & Chief Innovation Officer
Sell
5,566
$5.42
$30.17K
Michael Overdorf
2 Mar 2026
EVP & Chief Business Officer
Sell
4,339
$5.42
$23.52K
Jamie Dananberg
2 Mar 2026
Chief Medical Officer
Sell
5,820
$5.43
$31.60K
Michael Overdorf
18 Feb 2026
EVP & Chief Business Officer
Sell
6,225
$5.10
$31.75K
Ted Yednock
18 Feb 2026
EVP & Chief Innovation Officer
Sell
7,857
$5.11
$40.15K
Dean Richard Artis
18 Feb 2026
EVP & Chief Scientific Officer
Sell
5,290
$5.10
$26.98K
Jennifer Lew
18 Feb 2026
EVP & Chief Financial Officer
Sell
7,851
$5.11
$40.12K
Jamie Dananberg
18 Feb 2026
Chief Medical Officer
Sell
5,290
$5.10
$26.98K
William H. Carson
30 Dec 2025
Director
Buy
4,115
$5.02
$20.66K
William H. Carson
1 Dec 2025
Director
Buy
4,115
$4.47
$18.39K
Jung Choi
1 Dec 2025
Director
Buy indirect
33,000
$4.19
$138.27K
Muneer A Satter
21 Nov 2025
Director
Buy indirect
422,613
$4.28
$1.81M
Muneer A Satter
20 Nov 2025
Director
Buy indirect
400,000
$4.48
$1.79M
Muneer A Satter
19 Nov 2025
Director
Buy indirect
500,000
$3.94
$1.97M
Muneer A Satter
18 Nov 2025
Director
Buy indirect
500,000
$3.18
$1.59M
Muneer A Satter
17 Nov 2025
Director
Buy indirect
500,000
$2.99
$1.50M

What was left out

Form 4 filings counted 34
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 336,896
History held since 24 Jul 2020